Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

Show full item record



Permalink

http://hdl.handle.net/10138/335939

Citation

Januszewski , A S , Chen , D , Scott , R S , O'Connell , R L , Aryal , N R , Sullivan , D R , Watts , G F , Taskinen , M-R , Barter , P J , Best , J D , Simes , R J , Keech , A C & Jenkins , A J 2021 , ' Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes ' , Scientific Reports , vol. 11 , no. 1 , 18708 . https://doi.org/10.1038/s41598-021-98064-y

Title: Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes
Author: Januszewski, Andrzej S.; Chen, David; Scott, Russell S.; O'Connell, Rachel L.; Aryal, Nanda R.; Sullivan, David R.; Watts, Gerald F.; Taskinen, Marja-Riitta; Barter, Philip J.; Best, James D.; Simes, R. John; Keech, Anthony C.; Jenkins, Alicia J.
Contributor: University of Helsinki, Clinicum
Date: 2021-09-21
Language: eng
Number of pages: 12
Belongs to series: Scientific Reports
ISSN: 2045-2322
URI: http://hdl.handle.net/10138/335939
Abstract: People with diabetes are at risk of chronic complications and novel biomarkers, such as Advanced glycation end-products (AGEs) may help stratify this risk. We assessed whether plasma low-molecular weight AGEs, also known as LMW-fluorophores (LMW-F), are associated with risk factors, predict complications, and are altered by fenofibrate in adults with type 2 diabetes. Plasma LMW-F were quantified at baseline, after six weeks fenofibrate, and one year post-randomisation to fenofibrate or placebo. LMW-F associations with existing and new composite vascular complications were determined, and effects of fenofibrate assessed. LMW-F correlated positively with age, glycated haemoglobin (HbA1c), pulse pressure, kidney dysfunction and inflammation; and negatively with urate, body mass index, oxidative stress and leptin, albeit weakly (r = 0.04-0.16, all p < 0.01). Independent determinants of LMW-F included smoking, diastolic blood pressure, prior cardiovascular disease or microvascular complications, Caucasian ethnicity, kidney function, HbA1c and diabetes duration (all p
Subject: GLYCATION END-PRODUCTS
AGE-PEPTIDES
FLUORESCENCE
SERUM
ACCUMULATION
ENDPRODUCTS
RETINOPATHY
MELLITUS
EVENTS
PEOPLE
3121 General medicine, internal medicine and other clinical medicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
s41598_021_98064_y.pdf 1.799Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record